Found 7 matching trials
Evaluation of ALD403 (Eptinezumab) in the Prevention of Chronic Migraine
PHASE3The purpose of this study is to assess the efficacy and safety of ALD403 in...
Migraine Induction Properties of PACAP-38 After Eptinezumab in Migraine Without Aura Patients.
NATo investigate whether administration of calcitonin gene-related peptide (C...
Location
Danish headache center
A Multicenter Assessment of ALD403 in Chronic Migraine
PHASE2The purpose of this study is to assess ALD403 in the prevention of migraine...
An Open Label Trial of ALD403 (Eptinezumab) in Chronic Migraine
PHASE3An evaluation of long term safety of repeat ALD403 doses in Chronic Migrain...
Safety Tolerability and Pharmacokinetics of ALD403
PHASE1The purpose of this study is to determine the safety, tolerability and phar...
Location
Centre for Clinical Studies, Nucleus Network
Safety, Efficacy and Pharmacokinetics of ALD403
PHASE1The purpose of this study is to assess the safety, pharmacokinetics and eff...
Location
Premiere Research
A Multicenter Assessment of ALD403 in Frequent Episodic Migraine
PHASE3The purpose of this study is to assess ALD403 in the prevention of migraine...